ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,024Medicare Part D Prescriptions Filled, Including Refills

Rank: 285 out of 2343

$701K Total Retail Price of All Prescriptions

Rank: 326 out of 2343

437 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
30% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 437 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

11% of this provider’s 437 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 12,084 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
AMLODIPINE BESYLATE 572 555 1 5
LEVOTHYROXINE SODIUM 568 536 2 2
WARFARIN SODIUM 451 449 3 8
LISINOPRIL 362 324 4 3
OMEPRAZOLE 319 280 5 4
SIMVASTATIN 311 276 6 1
FUROSEMIDE 311 292 6 6
METOPROLOL TARTRATE 279 278 8 7
NAMENDA 267 267 9 36
PANTOPRAZOLE SODIUM 230 224 10 22
CITALOPRAM HBR 211 203 11 17
HYDROCODONE-ACETAMINOPHEN 201 179 S3 12 13
SERTRALINE HCL 180 157 13 20
DONEPEZIL HCL 174 174 14 21
POLYETHYLENE GLYCOL 3350 172 172 15 54
PREDNISONE 164 162 16 37
METOPROLOL SUCCINATE 145 129 17 14
ATENOLOL 140 100 18 12
ALLOPURINOL 137 137 19 31
ATORVASTATIN CALCIUM 134 120 20 10
ESCITALOPRAM OXALATE 132 126 21 55
HYDROCHLOROTHIAZIDE 130 120 22 11
GABAPENTIN 128 111 23 16
MIRTAZAPINE 126 125 24 41
FLUDROCORTISONE ACETATE 122 122 25 361
ISOSORBIDE MONONITRATE ER 119 118 26 32
LOSARTAN POTASSIUM 119 117 26 19
EXELON 119 119 26 129
METFORMIN HCL 110 105 29 9
BUMETANIDE 107 101 30 91
CEPHALEXIN 105 103 31 111
TAMSULOSIN HCL 105 105 31 29
HYDRALAZINE HCL 102 102 33 92
CARBIDOPA-LEVODOPA 101 101 34 85
KLOR-CON M20 100 100 35 44
CLOPIDOGREL 98 95 36 26
ADVAIR DISKUS 97 95 37 34
PRAVASTATIN SODIUM 91 84 38 15
SPIRONOLACTONE 87 82 39 65
NYAMYC 83 83 40 434
VOLTAREN 81 81 41 175
DIOVAN 77 61 42 23
IPRATROPIUM-ALBUTEROL 74 74 43 99
CARVEDILOL 73 64 44 27
VENLAFAXINE HCL ER 73 70 44 87
DILTIAZEM 24HR CD 73 73 44 83
TRAMADOL HCL 72 68 47 25
JANUVIA 72 72 47 50
PLAVIX 70 67 49 38
CIPROFLOXACIN HCL 68 66 50 72
FENTANYL 68 65 S2 50 69
OLANZAPINE 65 65 52 121
MECLIZINE HCL 63 49 53 103
NYSTATIN 62 61 54 172
LIDODERM 62 61 54 130
GLIMEPIRIDE 60 60 56 45
ALENDRONATE SODIUM 60 60 56 28
FENOFIBRATE 58 45 58 94
AMITRIPTYLINE HCL 57 45 R 59 117
DOXYCYCLINE HYCLATE 57 54 59 180
LYRICA 56 42 61 135
CALCITONIN-SALMON 54 54 62 323
BUSPIRONE HCL 54 48 62 146
DIGOXIN 53 53 64 35
FLUTICASONE PROPIONATE 51 39 65 46
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 30, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.